Larvol Veri

BIOMARKER:

FGFR2 overexpression

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

FGFR2 overexpression FGFR2 overexpression	Gastric Cancer Gastric Cancer	FPA-144 Sensitive: C2 – Inclusion Criteria FPA-144 Sensitive : C2
FGFR2 overexpression FGFR2 overexpression	Gastrointestinal Cancer Gastrointestinal Cancer	ARQ 087 Sensitive: D – Preclinical ARQ 087 Sensitive : D
FGFR2 overexpression FGFR2 overexpression	Breast Cancer Breast Cancer	ponatinib Sensitive: D – Preclinical ponatinib Sensitive : D